Receiving GAZYVA for relapsed or
refractory follicular lymphoma
How and when am I given GAZYVA?
GAZYVA is given as an infusion. This means it goes directly into your vein through a needle in your arm. You’ll get your treatment with GAZYVA at a clinic or infusion center.
GAZYVA in combination with bendamustine is given for a total of 6 cycles, or rounds, of treatment. Each cycle will last 28 days. If your disease has not progressed during the initial 6 cycles, your doctor may recommend GAZYVA alone once every 2 months for 2 years. Treatment occurs only on certain days of each cycle, and that is usually followed by several weeks of rest and recovery.
Each dose of GAZYVA is the same. Some patients may have side effects during the infusion process. Please refer to the safety information section for more information about these reactions.
GAZYVA® (obinutuzumab) is a prescription medicine used with the chemotherapy drug, bendamustine, followed by GAZYVA alone for the treatment of patients with follicular lymphoma (FL) who relapsed after, or are refractory to, a rituximab-containing regimen.
Below is the chart that shows when you should receive GAZYVA and bendamustine infusions.
For Cycle 1, you will receive GAZYVA on Days 1, 8, and 15; and bendamustine on Days 1 and 2.
For Cycles 2 through 6, you will receive GAZYVA on the first day of each cycle (once every 28 days); and bendamustine on Days 1 and 2.
If you complete Cycles 1 through 6 and your disease has not progressed, your doctor may recommend GAZYVA alone once every 2 months for 2 years.